Surge in respiratory illnesses reported in China

As­traZeneca and Dai­ichi Sankyo’s TROP2-di­rect­ed an­ti­body-drug con­ju­gate failed a key sur­vival end­point in a late-phase breast can­cer study, po­ten­tial­ly throw­ing a wrench in­to its on­go­ing

Women who experienced severe maternal morbidity with their first birth were less likely to have more children, a retrospective Swedish population-based cohort study suggested. Among